DEERFIELD, Ill., June 18, 2013 - Walgreens (NYSE: WAG) (Nasdaq: WAG) will release its fiscal 2013 third quarter earnings results at 7:30 a.m. Eastern time Tuesday, June 25, followed by a conference call with Walgreens management beginning at 8:30 a.m. Eastern time.

• Company reports adjusted second quarter earnings per diluted share of 96 cents, compared with adjusted earnings per diluted share of 88 cents in year-ago quarter; GAAP earnings per diluted share of 79 cents compared with 78 cents in last year’s second quarter
• Cash flow from operations reaches second-quarter record $1.2 billion
• Alliance Boots and joint synergy program on track to deliver first-year targets
• Walgreens and Alliance Boots form strategic, long-term relationship with AmerisourceBergen; includes 10-year comprehensive agreement for AmerisourceBergen to handle pharmaceutical distribution for Walgreens

DEERFIELD, Ill., March 19, 2013 - Walgreen Co. (NYSE, NASDAQ: WAG) today announced earnings and sales results for the second quarter and first half of fiscal year 2013 ended Feb. 28.
 

DEERFIELD, Ill., December 21, 2012 - Walgreen Co. (NYSE: WAG) (Nasdaq: WAG) today announced earnings and sales results for the first quarter of fiscal year 2013 ended Nov. 30.

Net earnings determined in accordance with generally accepted accounting principles (GAAP) for the fiscal 2013 first quarter were $413 million or 43 cents per diluted share, compared with $554 million or 63 cents per diluted share in the year-ago quarter.

DEERFIELD, Ill., December 18, 2012 - Walgreens (NYSE: WAG) (Nasdaq: WAG) will release its fiscal 2013 first quarter earnings results at 7:30 a.m. Eastern time Friday, Dec. 21, followed by a conference call with Walgreens management beginning at 8:30 a.m. Eastern time.

• Company reports adjusted fourth quarter earnings per diluted share of 63 cents, compared with adjusted earnings per diluted share of 66 cents in year-ago quarter; GAAP earnings per diluted share of 39 cents compared with 87 cents in last year’s fourth quarter, including impact of Alliance Boots transaction this year and sale of company’s pharmacy benefit management business in last year’s quarter
• Fiscal 2012 sales total $71.6 billion compared with $72.2 billion in prior year, with adjusted earnings per diluted share of $2.93 compared with $2.93 in previous year; GAAP fiscal year earnings per diluted share total $2.42 compared with $2.94 in previous year
• Company generates record operating and free cash flow of $4.4 billion and $2.9 billion, respectively, in fiscal year 2012, allowing return of more than $1.9 billion to shareholders in share repurchases and dividends
• New fiscal year under way with participation in Express Scripts pharmacy network and launch of Balance™ Rewards loyalty program

DEERFIELD, Ill., September 28, 2012 - Walgreen Co. (NYSE, NASDAQ: WAG) today announced earnings and sales results for the fourth quarter and fiscal year 2012 ended Aug. 31.

Net earnings determined in accordance with generally accepted accounting principles (GAAP) for the fiscal 2012 fourth quarter were $353 million or 39 cents per diluted share, compared with $792 million or 87 cents per diluted share in the year-ago quarter.